348 related articles for article (PubMed ID: 22340721)
21. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
Bialy L; Waldmann H
Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
[TBL] [Abstract][Full Text] [Related]
22. Tyrosine phosphatases such as SHP-2 act in a balance with Src-family kinases in stabilization of postsynaptic clusters of acetylcholine receptors.
Camilleri AA; Willmann R; Sadasivam G; Lin S; Rüegg MA; Gesemann M; Fuhrer C
BMC Neurosci; 2007 Jul; 8():46. PubMed ID: 17605785
[TBL] [Abstract][Full Text] [Related]
23. The activated insulin-like growth factor I receptor induces depolarization in breast epithelial cells characterized by actin filament disassembly and tyrosine dephosphorylation of FAK, Cas, and paxillin.
Guvakova MA; Surmacz E
Exp Cell Res; 1999 Aug; 251(1):244-55. PubMed ID: 10438590
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic Targeting of Oncogenic Tyrosine Phosphatases.
Frankson R; Yu ZH; Bai Y; Li Q; Zhang RY; Zhang ZY
Cancer Res; 2017 Nov; 77(21):5701-5705. PubMed ID: 28855209
[TBL] [Abstract][Full Text] [Related]
25. Stepping out of the shadows: Oncogenic and tumor-promoting protein tyrosine phosphatases.
Elson A
Int J Biochem Cell Biol; 2018 Mar; 96():135-147. PubMed ID: 28941747
[TBL] [Abstract][Full Text] [Related]
26. Expression of protein tyrosine phosphatases and its significance in esophageal cancer.
Warabi M; Nemoto T; Ohashi K; Kitagawa M; Hirokawa K
Exp Mol Pathol; 2000 Jun; 68(3):187-95. PubMed ID: 10816386
[TBL] [Abstract][Full Text] [Related]
27. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer.
Laczmanska I; Sasiadek MM
Acta Biochim Pol; 2011; 58(4):467-70. PubMed ID: 22146137
[TBL] [Abstract][Full Text] [Related]
28. Histochemically demonstrable protein tyrosine phosphatase in human breast and colorectal cancer: large decrease in its activity in colorectal cancer suggests a tumor suppressor role in colorectal mucosal cells.
Partanen S
Anticancer Res; 1996; 16(2):943-6. PubMed ID: 8687156
[TBL] [Abstract][Full Text] [Related]
29. Protein tyrosine phosphatases, new targets for cancer therapy.
Easty D; Gallagher W; Bennett DC
Curr Cancer Drug Targets; 2006 Sep; 6(6):519-32. PubMed ID: 17017875
[TBL] [Abstract][Full Text] [Related]
30. Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.
Bollu LR; Mazumdar A; Savage MI; Brown PH
Clin Cancer Res; 2017 May; 23(9):2136-2142. PubMed ID: 28087641
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
[TBL] [Abstract][Full Text] [Related]
32. K vitamins, PTP antagonism, and cell growth arrest.
Carr BI; Wang Z; Kar S
J Cell Physiol; 2002 Dec; 193(3):263-74. PubMed ID: 12384979
[TBL] [Abstract][Full Text] [Related]
33. The tyrosine phosphatase Shp2 (PTPN11) in cancer.
Chan G; Kalaitzidis D; Neel BG
Cancer Metastasis Rev; 2008 Jun; 27(2):179-92. PubMed ID: 18286234
[TBL] [Abstract][Full Text] [Related]
34. Dual-specificity phosphatases as targets for antineoplastic agents.
Lyon MA; Ducruet AP; Wipf P; Lazo JS
Nat Rev Drug Discov; 2002 Dec; 1(12):961-76. PubMed ID: 12461518
[TBL] [Abstract][Full Text] [Related]
35. Suppression of metastatic potential of high-metastatic Lewis lung carcinoma cells by vanadate, an inhibitor of tyrosine phosphatase, through inhibiting cell-substrate adhesion.
Takenaga K
Invasion Metastasis; 1996; 16(2):97-106. PubMed ID: 9030244
[TBL] [Abstract][Full Text] [Related]
36. Alteration of phosphotyrosine-containing proteins during differentiation of chicken erythroleukemia cells (HD3).
Grdisa M
Cell Biochem Funct; 1998 Dec; 16(4):277-82. PubMed ID: 9857490
[TBL] [Abstract][Full Text] [Related]
37. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
38. Oxidation and tyrosine phosphorylation: synergistic or antagonistic cues in protein tyrosine phosphatase.
Chiarugi P; Taddei ML; Ramponi G
Cell Mol Life Sci; 2005 May; 62(9):931-6. PubMed ID: 15798896
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphorylation and reversible oxidation: two cross-talking posttranslation modifications.
Chiarugi P; Buricchi F
Antioxid Redox Signal; 2007 Jan; 9(1):1-24. PubMed ID: 17115885
[TBL] [Abstract][Full Text] [Related]
40. Protein tyrosine phosphatases as drug targets: PTP1B and beyond.
Hooft van Huijsduijnen R; Wälchli S; Ibberson M; Harrenga A
Expert Opin Ther Targets; 2002 Dec; 6(6):637-47. PubMed ID: 12472377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
